Meeting of the National Advisory Council on the National Health Service Corps, 7192-7193 [2022-02606]

Download as PDF 7192 Federal Register / Vol. 87, No. 26 / Tuesday, February 8, 2022 / Notices TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued 21 CFR section; activity Form FDA No. Amendment to an existing notification (170.101), amendment to a Pre-notification Consultation, or amendment to a Master File (concerning a food contact substance) 9. 171.1; Indirect Food Additive Petitions ........................ Use of Recycled Plastics in Food Packaging: Chemistry Considerations. Preparation of Food Contact Notifications for Food Contact Substances in Contact with Infant Formula and/or Human Milk. Total ...................................................................... Number of responses per respondent Number of respondents Total annual responses Average burden per response Total hours 3480A 80 1 80 0.5 (30 minutes) ......... 40 N/A N/A 1 65 1 1 1 65 10,995 ......................... 25 ................................ 10,995 1,625 ........................ 2 1 2 5 .................................. 10 ........................ ........................ ........................ ........................ ..................................... 32,675 1 There are no capital costs or operating and maintenance costs associated with this collection of information. 2 Notifications for food contact substance formulations and food contact articles. These notifications require the submission of Form FDA 3479 (‘‘Notification for a Food Contact Substance Formulation’’) only. 3 Duplicate notifications for uses of food contact substances. 4 Notifications for uses that are the subject of exemptions under 21 CFR 170.39 and very simple food additive petitions. 5 Notifications for uses that are the subject of moderately complex food additive petitions. 6 Notifications for uses that are the subject of very complex food additive petitions. 7 These notifications require the submission of Form FDA 3480. 8 These notifications recommend the submission of Form FDA 3480. 9 These notifications recommend the submission of Form FDA 3480A. Based on a review of the information collection since our last request for OMB approval, we made adjustments to our burden estimate. The estimates are based on our current experience with the Food Contact Substance Notification Program and informal communication with industry. Our estimated burden for the information collection reflects an overall increase of 1,345 hours and a corresponding decrease of 5 responses. We attribute this adjustment to a decrease in Pre-Notification Consultations or Master Files by 40 responses, a subsequent decrease of amendments to Pre-Notification Consultations or Master Files by 20 responses, and an increase of 55 respondents using the recommendations in the guidance document entitled ‘‘Use of Recycled Plastics in Food Packaging: Chemistry Considerations.’’ As the average burden for preparing recycling submissions is higher than for Prenotification Consultations or Master Files, this results in an overall increase in total burden even with an overall decrease in responses. Dated: February 2, 2022. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2022–02620 Filed 2–7–22; 8:45 am] khammond on DSKJM1Z7X2PROD with NOTICES BILLING CODE 4164–01–P VerDate Sep<11>2014 16:16 Feb 07, 2022 Jkt 256001 remotely will be posted. In-person NACNHSC meetings will be held at 5600 Fishers Lane, Rockville, Maryland Health Resources and Services 20857. For meeting information Administration updates, go to the meetings page on the NACNHSC website at https:// Meeting of the National Advisory www.hrsa.gov/advisory-committees/ Council on the National Health Service national-health-service-corps/meetings. Corps FOR FURTHER INFORMATION CONTACT: Diane Fabiyi-King, Designated Federal AGENCY: Health Resources and Services Official, Division of National Health Administration (HRSA), Department of Service Corps, HRSA, 5600 Fishers Health and Human Services. Lane, Rockville, Maryland 20857; phone ACTION: Notice. (301) 443–3609; or SUMMARY: In accordance with the NHSCAdvisoryCouncil@hrsa.gov. Federal Advisory Committee Act, this SUPPLEMENTARY INFORMATION: The notice announces that the National NACNHSC consults with, advises, and Advisory Council on the National makes recommendations to the Health Service Corps (NACNHSC) will Secretary of Health and Human Services hold public meetings for the 2022 with respect to the Secretary’s calendar year (CY). Information about responsibilities in carrying out Subpart NACNHSC, agendas, and materials for II, Part D of Title III of the Public Health these meetings can be found on the Service Act (42 U.S.C. 254d–254k), as NACNHSC website at: https:// amended, including the designation of www.hrsa.gov/advisory-committees/ areas of the United States with health national-health-service-corps. professional shortages and assignment DATES: NACNHSC meetings will be held of National Health Service Corps on: (NHSC) clinicians to improve the • March 29, 2022, 9:00 a.m.–5:00 p.m. delivery of health services in health Eastern Time (ET) and March 30, 2022, professional shortage areas. Since 9:00 a.m.–2:00 p.m. ET; priorities dictate meeting times, be • June 28, 2022, 9:00 a.m.–5:00 p.m. advised that start times, end times, and ET and June 29, 2022, 9:00 a.m.–2:00 agenda items are subject to change. p.m. ET; and Refer to the meeting website listed • November 15, 2022, 9:00 a.m.–5:00 above for any meeting updates. p.m. ET and November 16, 2022, 9:00 For CY 2022 meetings, agenda items a.m.–2:00 p.m. ET. may include, but are not limited to, the identification of NHSC priorities for ADDRESSES: Meetings may be held infuture program issues and concerns; person, by teleconference, and/or proposed policy changes by using the ZOOM. For updates on how meetings varying levels of expertise represented will be held, visit the NACNHSC website 30 business days before the date on the NACNHSC to advise on specific program areas; updates from clinician of the meeting, where instructions for workforce experts; and education and joining meetings either in-person or DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 Frm 00109 Fmt 4703 Sfmt 4703 E:\FR\FM\08FEN1.SGM 08FEN1 Federal Register / Vol. 87, No. 26 / Tuesday, February 8, 2022 / Notices practice improvement in the training development of primary care clinicians. More general items may include: Presentations and discussions on the current and emerging needs of the health workforce; public health priorities; health care access and evaluation; NHSC-approved sites; HRSA priorities and other federal health workforce and education programs that impact the NHSC. Refer to the NACNHSC website listed above for all current and updated information concerning the CY 2022 NACNHSC meetings, including draft agendas and meeting materials that will be posted 30 calendar days before the meeting. Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting(s). Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to the NACNHSC should be sent to Diane Fabiyi-King using the contact information above at least 5 business days before the meeting date(s). Individuals who need special assistance or another reasonable accommodation should notify Diane Fabiyi-King using the contact information listed above at least 10 business days before the meeting(s) they wish to attend. If in-person meetings are held, they will occur in a federal government building and attendees must go through a security check to enter the building. All in-person attendees must follow the workplace safety protocols regarding COVID–19. Guidance is provided on the website https://www.saferfederalworkforce.gov/. Non-U.S. citizen attendees must notify HRSA of their planned attendance at an in-person meeting at least 20 business days prior to the meeting in order to facilitate their entry into the building. All attendees are required to present government-issued identification prior to entry. khammond on DSKJM1Z7X2PROD with NOTICES Maria G. Button, Director, Executive Secretariat. [FR Doc. 2022–02606 Filed 2–7–22; 8:45 am] BILLING CODE 4165–15–P VerDate Sep<11>2014 16:16 Feb 07, 2022 Jkt 256001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Mechanisms of Memory and Sound Processing. Date: March 11, 2022. Time: 10:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sepandarmaz Aschrafi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4040D, Bethesda, MD 20892, (301) 451.4251, Armaz.aschrafi@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: HIV/AIDS Biological. Date: March 14, 2022. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Shahrooz Vahedi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 810G, Bethesda, MD 20892, (301) 496–9322, vahedis@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Chemistry, Biochemistry and Biophysics B. Date: March 15–16, 2022. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ian Frederick Thorpe, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480–8662, ian.thorpe@nih.gov. PO 00000 Frm 00110 Fmt 4703 Sfmt 4703 7193 Name of Committee: Center for Scientific Review Special Emphasis Panel; BRAIN Initiative: Targeted BRAIN Circuits Projects. Date: March 16–17, 2022. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301–435– 1242, kgt@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: The Cancer Drug Development and Therapeutics (CDDT). Date: March 17–18, 2022. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Lilia Topol, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301–451– 0131, ltopol@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Innate Immunity and Inflammatory Responses. Date: March 17, 2022. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Liying Guo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4198, MSC 7812, Bethesda, MD 20892, (301) 827– 7728, lguo@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Digestive Sciences Small Business Activities. Date: March 17, 2022. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Santanu Banerjee, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2106, Bethesda, MD 20892, (301) 435–5947, banerjees5@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Bacterial Pathogenesis. Date: March 17–18, 2022. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). E:\FR\FM\08FEN1.SGM 08FEN1

Agencies

[Federal Register Volume 87, Number 26 (Tuesday, February 8, 2022)]
[Notices]
[Pages 7192-7193]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02606]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the National Advisory Council on the National Health 
Service Corps

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the National Advisory Council on the National 
Health Service Corps (NACNHSC) will hold public meetings for the 2022 
calendar year (CY). Information about NACNHSC, agendas, and materials 
for these meetings can be found on the NACNHSC website at: https://www.hrsa.gov/advisory-committees/national-health-service-corps.

DATES: NACNHSC meetings will be held on:
     March 29, 2022, 9:00 a.m.-5:00 p.m. Eastern Time (ET) and 
March 30, 2022, 9:00 a.m.-2:00 p.m. ET;
     June 28, 2022, 9:00 a.m.-5:00 p.m. ET and June 29, 2022, 
9:00 a.m.-2:00 p.m. ET; and
     November 15, 2022, 9:00 a.m.-5:00 p.m. ET and November 16, 
2022, 9:00 a.m.-2:00 p.m. ET.

ADDRESSES: Meetings may be held in-person, by teleconference, and/or 
ZOOM. For updates on how meetings will be held, visit the NACNHSC 
website 30 business days before the date of the meeting, where 
instructions for joining meetings either in-person or remotely will be 
posted. In-person NACNHSC meetings will be held at 5600 Fishers Lane, 
Rockville, Maryland 20857. For meeting information updates, go to the 
meetings page on the NACNHSC website at https://www.hrsa.gov/advisory-committees/national-health-service-corps/meetings.

FOR FURTHER INFORMATION CONTACT: Diane Fabiyi-King, Designated Federal 
Official, Division of National Health Service Corps, HRSA, 5600 Fishers 
Lane, Rockville, Maryland 20857; phone (301) 443-3609; or 
[email protected].

SUPPLEMENTARY INFORMATION: The NACNHSC consults with, advises, and 
makes recommendations to the Secretary of Health and Human Services 
with respect to the Secretary's responsibilities in carrying out 
Subpart II, Part D of Title III of the Public Health Service Act (42 
U.S.C. 254d-254k), as amended, including the designation of areas of 
the United States with health professional shortages and assignment of 
National Health Service Corps (NHSC) clinicians to improve the delivery 
of health services in health professional shortage areas. Since 
priorities dictate meeting times, be advised that start times, end 
times, and agenda items are subject to change. Refer to the meeting 
website listed above for any meeting updates.
    For CY 2022 meetings, agenda items may include, but are not limited 
to, the identification of NHSC priorities for future program issues and 
concerns; proposed policy changes by using the varying levels of 
expertise represented on the NACNHSC to advise on specific program 
areas; updates from clinician workforce experts; and education and

[[Page 7193]]

practice improvement in the training development of primary care 
clinicians. More general items may include: Presentations and 
discussions on the current and emerging needs of the health workforce; 
public health priorities; health care access and evaluation; NHSC-
approved sites; HRSA priorities and other federal health workforce and 
education programs that impact the NHSC.
    Refer to the NACNHSC website listed above for all current and 
updated information concerning the CY 2022 NACNHSC meetings, including 
draft agendas and meeting materials that will be posted 30 calendar 
days before the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting(s). Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to the NACNHSC should 
be sent to Diane Fabiyi-King using the contact information above at 
least 5 business days before the meeting date(s).
    Individuals who need special assistance or another reasonable 
accommodation should notify Diane Fabiyi-King using the contact 
information listed above at least 10 business days before the 
meeting(s) they wish to attend. If in-person meetings are held, they 
will occur in a federal government building and attendees must go 
through a security check to enter the building. All in-person attendees 
must follow the workplace safety protocols regarding COVID-19. Guidance 
is provided on the website https://www.saferfederalworkforce.gov/. Non-
U.S. citizen attendees must notify HRSA of their planned attendance at 
an in-person meeting at least 20 business days prior to the meeting in 
order to facilitate their entry into the building. All attendees are 
required to present government-issued identification prior to entry.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-02606 Filed 2-7-22; 8:45 am]
BILLING CODE 4165-15-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.